BRIACELL THERAPEUTICS CORP (BCTX)
CA10778Y3023 - Common Stock
| TTM (2024-1-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.69M | -20.30M | -26.84M | -13.82M | -3.64M | |||
| Depreciation Amortization | 15.27K | 15.27K | 15.27K | 15.26K | 13.79K | |||
| Change In Working Capital | -2.11M | -3.53M | -391.29K | -2.28M | 2.41M | |||
| Other non cash items | -16.48M | 74.26K | 14.73M | 8.33M | 65.34K | |||
| OPERATING CASH FLOW | -31.26M | -23.74M | -12.48M | -7.75M | -1.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -23.58K | -330.40K | 20.31K | |||
| Stock Issued/Repurchased | 4.00M | 3.95M | -3.66M | 65.33M | 1.04M | |||
| Other Financing Activity | N/A | 0.00 | -57.12K | 0.00 | N/A | |||
| FINANCING CASH FLOW | 4.00M | 3.95M | -3.74M | 65.00M | 1.06M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | -39.73K | |||
| CHANGE IN CASH | -27.26M | -19.79M | -16.23M | 57.25M | -122.74K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.26M | -23.74M | -12.48M | -7.75M | -1.14M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -31.26M | -23.74M | -12.48M | -7.75M | -1.14M | |||
All data in USD